RANDAL S WEBER to Disease Progression
This is a "connection" page, showing publications RANDAL S WEBER has written about Disease Progression.
Connection Strength
0.083
-
Management of locally invasive well-differentiated thyroid cancer. Surg Oncol Clin N Am. 2008 Jan; 17(1):145-55, ix.
Score: 0.035
-
Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity. J Clin Oncol. 2014 Dec 01; 32(34):3858-66.
Score: 0.014
-
Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res. 2014 Dec 15; 20(24):6582-92.
Score: 0.014
-
Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression. Clin Cancer Res. 2007 Nov 01; 13(21):6532-9.
Score: 0.009
-
Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression. Am J Pathol. 2000 Dec; 157(6):1777-83.
Score: 0.005
-
A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy of unrespectable head and neck cancer. Int J Radiat Oncol Biol Phys. 1999 May 01; 44(2):311-5.
Score: 0.005